Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X:
“Pleased to be at DIA 2025 today where I shared how we’re harnessing the power of AI and big data to revolutionize our approach at the FDA.
I’m committed to leading this FDA into a future where regulatory oversight is increasingly data-driven and patient-centric. The potential to improve lives through faster, more efficient processes is immense.”
More posts featuring Marty Makary on OncoDaily.